• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and tolerability of ethionamide versus prothionamide: a systematic review.

作者信息

Scardigli Anna, Caminero Jose A, Sotgiu Giovanni, Centis Rosella, D'Ambrosio Lia, Migliori Giovanni Battista

机构信息

MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease, Paris, France The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland These authors contributed equally.

MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease, Paris, France Pneumology Dept, General Hospital of Gran Canaria "Dr. Negrin", Las Palmas, Spain These authors contributed equally.

出版信息

Eur Respir J. 2016 Sep;48(3):946-52. doi: 10.1183/13993003.00438-2016. Epub 2016 Jun 10.

DOI:10.1183/13993003.00438-2016
PMID:27288034
Abstract
摘要

相似文献

1
Efficacy and tolerability of ethionamide versus prothionamide: a systematic review.乙硫异烟胺与丙硫异烟胺的疗效及耐受性：一项系统评价
Eur Respir J. 2016 Sep;48(3):946-52. doi: 10.1183/13993003.00438-2016. Epub 2016 Jun 10.
2
[Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
Klin Med (Mosk). 1976 Dec;54(12):72-8.
3
A comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients.
J Indian Med Assoc. 1977 Jan 16;68(2):25-9.
4
[Bacteriostatic activity of blood in single and combined use of ethionamide or prothionamide].
Probl Tuberk. 1975(5):70-3.
5
[Therapeutic efficiency of ethionamide and prothionamide].
Probl Tuberk. 1969;47(8):66-9.
6
A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.乙硫异烟胺和丙硫异烟胺治疗瘤型麻风的临床试验。
Am J Trop Med Hyg. 2006 Mar;74(3):457-61.
7
[Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
Probl Tuberk. 1969;47(1):27-33.
8
Further data on the effect of ethionamide and prothionamide in experimental leprosy.
Lepr Rev. 1978 Sep;49(3):199-202. doi: 10.5935/0305-7518.19780025.
9
Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review.
Lepr Rev. 1978 Jun;49(2):115-26. doi: 10.5935/0305-7518.19780014.
10
Metabolism of the antituberculosis drug ethionamide.抗结核药物乙硫异烟胺的代谢。
Curr Drug Metab. 2013 Jan;14(1):151-8.

引用本文的文献

1
Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon.变革性的结核病治疗：突破、挑战与未来的希望。
Acta Pharm Sin B. 2025 Mar;15(3):1311-1332. doi: 10.1016/j.apsb.2025.01.023. Epub 2025 Jan 31.
2
Perchlozone Resistance in Clinical Isolates of .临床分离株中的过氯唑抗性 。 你提供的原文似乎不完整，请补充完整以便我能更准确地翻译。
Antibiotics (Basel). 2023 Mar 15;12(3):590. doi: 10.3390/antibiotics12030590.
3
Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients.
采用群体药代动力学优化耐多药结核病患者的丙硫异烟胺剂量。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0189321. doi: 10.1128/aac.01893-21. Epub 2022 Aug 8.
4
Effectiveness and Safety of Short-term Regimen for Multidrug-resistant Tuberculosis Treatment: A Systematic Review of Cohort Studies.多药耐药结核病治疗短期方案的有效性和安全性：队列研究的系统评价
Oman Med J. 2022 Jan 31;37(1):e337. doi: 10.5001/omj.2021.64. eCollection 2022 Jan.
5
MDR Tuberculosis Treatment.耐多药结核病治疗。
Medicina (Kaunas). 2022 Jan 26;58(2):188. doi: 10.3390/medicina58020188.
6
Molecular Determinants of Ethionamide Resistance in Clinical Isolates of ..临床分离株中乙硫异烟胺耐药性的分子决定因素
Antibiotics (Basel). 2022 Jan 20;11(2):133. doi: 10.3390/antibiotics11020133.
7
Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis.乙硫异烟胺群体药代动力学模型及耐多药结核病的目标达成情况
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00713-20.
8
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.耐药结核病治疗。美国胸科学会/美国疾病控制与预防中心/欧洲呼吸学会/美国感染病学会临床实践指南。
Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST.
9
Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011-2016.2011 - 2016年美国耐多药结核病短程治疗方案的适用情况
Clin Infect Dis. 2020 Feb 14;70(5):907-916. doi: 10.1093/cid/ciz263.
10
Mutation EthA confers co-resistance to prothionamide and ethionamide in both BCG and H37Rv.EthA突变使卡介苗（BCG）和H37Rv对丙硫异烟胺和乙硫异烟胺产生共同耐药性。
Infect Drug Resist. 2018 Jun 13;11:891-894. doi: 10.2147/IDR.S163965. eCollection 2018.